Feds: Western Pennsylvanians duped into buying illegally imported ‘smart drugs’ | TribLIVE.com
Regional

Feds: Western Pennsylvanians duped into buying illegally imported ‘smart drugs’

Natasha Lindstrom
1786730_web1_gtr-hth-vitamins-112018

A Mercer County man pleaded guilty to plotting to sell to Western Pennsylvanians untested drugs from China and Russia that he claimed could make people smarter, federal prosecutors said.

Emil “Butch” Koledin, of Hermitage and the corporation he ran, Koledin Enterprises Inc., each entered guilty counts of conspiracy to defraud the federal government before U.S. District Judge Donetta W. Ambrose, U.S. Attorney Scott W. Brady said.

As part of his guilty plea, Emil Koledin admitted to using the now-defunct website, AwakeBrain.com, to sell products deemed “nootropics,” or drugs that can boost cognitive performance.

Koledin billed the products to customers as “smart drugs, memory enhancers, neuro-exchangers and intelligence enhancements.” They included: adrafinil, bromantane, coluracetam, etifoxine, phenylpiracetam, theanine and tianetine.

“He falsely represented these drugs as legal to sell in the United States,” prosecutors said.

The products did not have appropriate labels, directions nor warnings “because they were manufactured in unapproved facilities,” prosecutors said.

Koledin illegally brought the drugs to the U.S., prosecutors said.

Most were manufactured in China or Russia.

Koledin’s conviction carries a maximum possible sentence of five years in prison and a fine up to $250,000.

Assistant U.S. Attorney Brendan T. Conway prosecuted the case with help from the FDA’s Office of Criminal Investigations.

Natasha Lindstrom is a Tribune-Review staff writer. You can contact Natasha at 412-380-8514, [email protected] or via Twitter .

Categories: Local | Regional | Top Stories
TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.